Department of Oncology, the Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
Department of Oncology, Shenzhen Hospital of Southern Medical University, Shenzhen, 518000, Guangdong, China.
Support Care Cancer. 2023 Jul 7;31(7):447. doi: 10.1007/s00520-023-07929-7.
To evaluate the feasibility and practicability of Managing Cancer and Living Meaningfully (CALM) as a psychological intervention to reduce neutrophil to lymphocyte ratio (NLR), fear of cancer recurrence, general distress, and improve quality of life in lung cancer survivors.
Eighty lung cancer patients with FCRI severity subscale (≥13 points) were recruited and randomly assigned to CALM or usual care (UC). NLR was recorded before and after treatment. The Fear of Cancer Recurrence Inventory (FCRI), Quality of Life Questionnaire Core 30 (QLQ-C30) and Depression-Anxiety-Stress Scale (DASS-21) were used to evaluate patients at baseline (T0), immediately after treatment (T1), and at 2 (T2) and 4 (T3) months.
Compared with UC, NLR was significantly different before and after CALM intervention (z=-5.498; P=0.000). There were significant differences in the scores of QLQ, FCR and general distress before and after the T1, T2 and T3 interventions (F=220.30, F=315.20, F=290.10, respectively; P<0.001). NLR was negatively correlated with QOL both before (r=-0.763; P<0.0001) and after the intervention (r=-0.810, P<0.0001). FCR and general distress were negatively correlated with QOL in CALM (T0: r=-0.726, r=-0.776, respectively; P<0.0001; T1: r=-0.664, r=-0.647, respectively; P<0.0001; T2: r=-0.678, r=-0.695, respectively; P<0.0001; T3: r=-0.511, P = 0.0008; r=-0.650, P<0.0001).
CALM intervention can effectively reduce the NLR, alleviate the recurrence fear and general distress and improve the quality of life in patients. This study suggests that CALM may be an effective psychological intervention for reducing symptoms associated with lung cancer survivors.
评估管理癌症和有意义地生活(CALM)作为一种心理干预措施,以降低中性粒细胞与淋巴细胞比值(NLR)、癌症复发恐惧、一般困扰,并改善肺癌幸存者的生活质量的可行性和实用性。
招募了 80 名 FCRI 严重程度亚量表(≥13 分)的肺癌患者,并随机分配至 CALM 或常规护理(UC)组。治疗前后记录 NLR。采用癌症复发恐惧量表(FCRI)、生活质量问卷核心 30 项(QLQ-C30)和抑郁焦虑压力量表(DASS-21)在基线(T0)、治疗后即刻(T1)以及 2(T2)和 4(T3)个月时评估患者。
与 UC 相比,CALM 干预前后 NLR 差异有统计学意义(z=-5.498;P=0.000)。T1、T2 和 T3 干预前后 QLQ、FCR 和一般困扰评分差异均有统计学意义(F=220.30、F=315.20、F=290.10,P<0.001)。NLR 与干预前后的 QOL 均呈负相关(r=-0.763;P<0.0001;r=-0.810,P<0.0001)。CALM 中的 FCR 和一般困扰与 QOL 呈负相关(T0:r=-0.726、r=-0.776,P<0.0001;T1:r=-0.664、r=-0.647,P<0.0001;T2:r=-0.678、r=-0.695,P<0.0001;T3:r=-0.511,P=0.0008;r=-0.650,P<0.0001)。
CALM 干预可有效降低 NLR,减轻复发恐惧和一般困扰,提高患者生活质量。本研究提示 CALM 可能是一种减轻肺癌幸存者相关症状的有效心理干预措施。